Tag: CTCL MF Treatment
Actelion’s Ledaga Chlormethine Gel for CTCL MF treatment gets EC approval
Actelion recent news : The European Commission (EC) has approved Actelion Pharmaceuticals' marketing authorization for its Ledaga Chlormethine Gel 160 micrograms/g for cutaneous T-cell lymphoma ... Read More